InvestorsHub Logo
Followers 40
Posts 1456
Boards Moderated 0
Alias Born 09/23/2013

Re: None

Monday, 09/30/2013 10:40:11 AM

Monday, September 30, 2013 10:40:11 AM

Post# of 144814
What should get shareholders of Nuvilex excited about the company's future is the actual data the FDA used to quickly approve the ABRAXANE-gemcitabine combination for pancreatic cancer. $NVLX

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News